APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Artificial Blood Products Industry Growth and Trends Forecast to 2032

29 December 202592 pages

Choose your research edition.

Industry ResearchArtificial Blood Products Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Products Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Artificial Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Products Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Products Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Artificial Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Artificial Blood Products include SpheriTech Ltd., NuvOx Pharma, KaloCyte Inc., HEMARINA SA, HbO2 Therapeutics and Aurum Biosciences Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Artificial Blood Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artificial Blood Products market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Blood Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Blood Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Artificial Blood Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artificial Blood Products Market by Company

SpheriTech Ltd.

NuvOx Pharma

KaloCyte Inc.

HEMARINA SA

HbO2 Therapeutics

Aurum Biosciences Ltd.

Artificial Blood Products Segment by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Products Segment by Application

Military

Civil

Artificial Blood Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Artificial Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Perfluorocarbon-based Oxygen Carrier (PFBOC) Table 2. Major Company of Hemoglobin-based Oxygen Carrier (HBOC) Table 3. Global Artificial Blood Products Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 5. Global Artificial Blood Products Sales Market Share in Volume by Type (2021-2026) Table 6. Global Artificial Blood Products Sales by Type (2021-2026) & (US$ Million) Table 7. Global Artificial Blood Products Sales Market Share in Value by Type (2021-2026) Table 8. Global Artificial Blood Products Price by Type (2021-2026) & (US$/Unit) Table 9. Global Artificial Blood Products Sales by Type (2027-2032) & (K Units) Table 10. Global Artificial Blood Products Sales Market Share in Volume by Type (2027-2032) Table 11. Global Artificial Blood Products Sales by Type (2027-2032) & (US$ Million) Table 12. Global Artificial Blood Products Sales Market Share in Value by Type (2027-2032) Table 13. Global Artificial Blood Products Price by Type (2027-2032) & (US$/Unit) Table 14. North America Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 15. North America Artificial Blood Products Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 17. Europe Artificial Blood Products Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Artificial Blood Products Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 21. Latin America Artificial Blood Products Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Artificial Blood Products Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Artificial Blood Products Sales by Type (2021-2026) & (US$ Million) Table 24. Artificial Blood Products Industry Trends Table 25. Artificial Blood Products Industry Drivers Table 26. Artificial Blood Products Industry Opportunities and Challenges Table 27. Artificial Blood Products Industry Restraints Table 28. Global Artificial Blood Products Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Artificial Blood Products Revenue Market Share by Company (2021-2026) Table 30. Global Artificial Blood Products Sales by Company (2021-2026) & (K Units) Table 31. Global Artificial Blood Products Sales Share by Company (2021-2026) Table 32. Global Artificial Blood Products Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Artificial Blood Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Artificial Blood Products Major Company Production Sites and Headquarters Table 35. Global Artificial Blood Products Company, Product Type & Application Table 36. Global Artificial Blood Products Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Artificial Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Artificial Blood Products Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Artificial Blood Products Sales by Region (2021-2026) & (K Units) Table 41. Global Artificial Blood Products Sales Market Share in Volume by Region (2021-2026) Table 42. Global Artificial Blood Products Sales by Region (2021-2026) & (US$ Million) Table 43. Global Artificial Blood Products Sales Market Share in Value by Region (2021-2026) Table 44. Global Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Artificial Blood Products Sales by Region (2027-2032) & (K Units) Table 46. Global Artificial Blood Products Sales Market Share in Volume by Region (2027-2032) Table 47. Global Artificial Blood Products Sales by Region (2027-2032) & (US$ Million) Table 48. Global Artificial Blood Products Sales Market Share in Value by Region (2027-2032) Table 49. Global Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Artificial Blood Products Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 52. Global Artificial Blood Products Sales Market Share in Volume by Application (2021-2026) Table 53. Global Artificial Blood Products Sales by Application (2021-2026) & (US$ Million) Table 54. Global Artificial Blood Products Sales Market Share in Value by Application (2021-2026) Table 55. Global Artificial Blood Products Price by Application (2021-2026) & (US$/Unit) Table 56. Global Artificial Blood Products Sales by Application (2027-2032) & (K Units) Table 57. Global Artificial Blood Products Sales Market Share in Volume by Application (2027-2032) Table 58. Global Artificial Blood Products Sales by Application (2027-2032) & (US$ Million) Table 59. Global Artificial Blood Products Sales Market Share in Value by Application (2027-2032) Table 60. Global Artificial Blood Products Price by Application (2027-2032) & (US$/Unit) Table 61. North America Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 62. North America Artificial Blood Products Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 64. Europe Artificial Blood Products Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Artificial Blood Products Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 68. Latin America Artificial Blood Products Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Artificial Blood Products Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Artificial Blood Products Sales by Application (2021-2026) & (US$ Million) Table 71. SpheriTech Ltd. Company Information Table 72. SpheriTech Ltd. Business Overview Table 73. SpheriTech Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. SpheriTech Ltd. Artificial Blood Products Product Portfolio Table 75. SpheriTech Ltd. Recent Development Table 76. NuvOx Pharma Company Information Table 77. NuvOx Pharma Business Overview Table 78. NuvOx Pharma Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. NuvOx Pharma Artificial Blood Products Product Portfolio Table 80. NuvOx Pharma Recent Development Table 81. KaloCyte Inc. Company Information Table 82. KaloCyte Inc. Business Overview Table 83. KaloCyte Inc. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. KaloCyte Inc. Artificial Blood Products Product Portfolio Table 85. KaloCyte Inc. Recent Development Table 86. HEMARINA SA Company Information Table 87. HEMARINA SA Business Overview Table 88. HEMARINA SA Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. HEMARINA SA Artificial Blood Products Product Portfolio Table 90. HEMARINA SA Recent Development Table 91. HbO2 Therapeutics Company Information Table 92. HbO2 Therapeutics Business Overview Table 93. HbO2 Therapeutics Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. HbO2 Therapeutics Artificial Blood Products Product Portfolio Table 95. HbO2 Therapeutics Recent Development Table 96. Aurum Biosciences Ltd. Company Information Table 97. Aurum Biosciences Ltd. Business Overview Table 98. Aurum Biosciences Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio Table 100. Aurum Biosciences Ltd. Recent Development Table 101. North America Artificial Blood Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 103. North America Artificial Blood Products Sales Market Share by Country (2021-2026) Table 104. North America Artificial Blood Products Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Artificial Blood Products Sales Market Share Forecast by Country (2027-2032) Table 106. North America Artificial Blood Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Artificial Blood Products Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Artificial Blood Products Market Share by Country (2021-2026) Table 109. North America Artificial Blood Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Artificial Blood Products Market Share Forecast by Country (2027-2032) Table 111. Europe Artificial Blood Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 113. Europe Artificial Blood Products Sales Market Share by Country (2021-2026) Table 114. Europe Artificial Blood Products Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Artificial Blood Products Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Artificial Blood Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Artificial Blood Products Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Artificial Blood Products Market Share by Country (2021-2026) Table 119. Europe Artificial Blood Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Artificial Blood Products Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Artificial Blood Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Artificial Blood Products Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Artificial Blood Products Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Artificial Blood Products Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Artificial Blood Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Artificial Blood Products Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Artificial Blood Products Market Share by Country (2021-2026) Table 129. Asia-Pacific Artificial Blood Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Artificial Blood Products Market Share Forecast by Country (2027-2032) Table 131. Latin America Artificial Blood Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 133. Latin America Artificial Blood Products Sales Market Share by Country (2021-2026) Table 134. Latin America Artificial Blood Products Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Artificial Blood Products Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Artificial Blood Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Artificial Blood Products Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Artificial Blood Products Market Share by Country (2021-2026) Table 139. Latin America Artificial Blood Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Artificial Blood Products Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Artificial Blood Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Artificial Blood Products Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Artificial Blood Products Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Artificial Blood Products Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Artificial Blood Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Artificial Blood Products Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Artificial Blood Products Market Share by Country (2021-2026) Table 149. Middle East and Africa Artificial Blood Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Artificial Blood Products Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Artificial Blood Products Distributors List Table 154. Artificial Blood Products Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Artificial Blood Products Image Figure 2. Global Artificial Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Blood Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Blood Products Sales (2021-2032) & (K Units) Figure 5. Perfluorocarbon-based Oxygen Carrier (PFBOC) Image Figure 6. Global Perfluorocarbon-based Oxygen Carrier (PFBOC) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Hemoglobin-based Oxygen Carrier (HBOC) Image Figure 8. Global Hemoglobin-based Oxygen Carrier (HBOC) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Artificial Blood Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Artificial Blood Products Market Share by Type 2025 VS 2032 Figure 11. North America Artificial Blood Products Sales Market Share in Volume by Type in 2025 Figure 12. North America Artificial Blood Products Sales Market Share in Value by Type in 2025 Figure 13. Europe Artificial Blood Products Sales Market Share in Volume by Type in 2025 Figure 14. Europe Artificial Blood Products Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Artificial Blood Products Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Artificial Blood Products Sales Market Share in Value by Type in 2025 Figure 17. Latin America Artificial Blood Products Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Artificial Blood Products Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Artificial Blood Products Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Artificial Blood Products Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Artificial Blood Products Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Military Image Figure 24. Global Military Sales YoY Growth (2021-2032) & (K Units) Figure 25. Civil Image Figure 26. Global Civil Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Artificial Blood Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Artificial Blood Products Market Share by Application 2025 VS 2032 Figure 29. North America Artificial Blood Products Sales Market Share in Volume by Application in 2025 Figure 30. North America Artificial Blood Products Sales Market Share in Value by Application in 2025 Figure 31. Europe Artificial Blood Products Sales Market Share in Volume by Application in 2025 Figure 32. Europe Artificial Blood Products Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Artificial Blood Products Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Artificial Blood Products Sales Market Share in Value by Application in 2025 Figure 35. Latin America Artificial Blood Products Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Artificial Blood Products Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Artificial Blood Products Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Artificial Blood Products Sales Market Share in Value by Application in 2025 Figure 39. North America Artificial Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Artificial Blood Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Artificial Blood Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Artificial Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Artificial Blood Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Artificial Blood Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Artificial Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Artificial Blood Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Artificial Blood Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Artificial Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Artificial Blood Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Artificial Blood Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Artificial Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Artificial Blood Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Artificial Blood Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Artificial Blood Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Artificial Blood Products Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Artificial Blood Products Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Applications
  • Military
  • Civil
Companies covered
  • SpheriTech Ltd.
  • NuvOx Pharma
  • KaloCyte Inc.
  • HEMARINA SA
  • HbO2 Therapeutics
  • Aurum Biosciences Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artificial Blood Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Artificial Blood Products Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Artificial Blood Products Market by Type
  6. 1.3.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  7. 1.3.2 Hemoglobin-based Oxygen Carrier (HBOC)
  8. 1.4 Global Artificial Blood Products Market Size by Type
  9. 1.4.1 Global Artificial Blood Products Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Artificial Blood Products Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Artificial Blood Products Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Artificial Blood Products Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Artificial Blood Products Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Artificial Blood Products Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Artificial Blood Products Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Artificial Blood Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Artificial Blood Products Industry Trends
  2. 2.2 Artificial Blood Products Industry Drivers
  3. 2.3 Artificial Blood Products Industry Opportunities and Challenges
  4. 2.4 Artificial Blood Products Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Artificial Blood Products Revenue (2021-2026)
  2. 3.2 Global Top Players by Artificial Blood Products Sales (2021-2026)
  3. 3.3 Global Top Players by Artificial Blood Products Price (2021-2026)
  4. 3.4 Global Artificial Blood Products Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artificial Blood Products Major Company Production Sites & Headquarters
  6. 3.6 Global Artificial Blood Products Company, Product Type & Application
  7. 3.7 Global Artificial Blood Products Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artificial Blood Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artificial Blood Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artificial Blood Products Tier 1, Tier 2, and Tier 3
4 Artificial Blood Products Regional Status and Outlook
  1. 4.1 Global Artificial Blood Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Artificial Blood Products Historic Market Size by Region
  3. 4.2.1 Global Artificial Blood Products Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Artificial Blood Products Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Artificial Blood Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Artificial Blood Products Forecasted Market Size by Region
  7. 4.3.1 Global Artificial Blood Products Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Artificial Blood Products Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Artificial Blood Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Artificial Blood Products by Application
  1. 5.1 Artificial Blood Products Market by Application
  2. 5.1.1 Military
  3. 5.1.2 Civil
  4. 5.2 Global Artificial Blood Products Market Size by Application
  5. 5.2.1 Global Artificial Blood Products Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Artificial Blood Products Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Artificial Blood Products Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Artificial Blood Products Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Artificial Blood Products Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Artificial Blood Products Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Artificial Blood Products Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Artificial Blood Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 SpheriTech Ltd.
  2. 6.1.1 SpheriTech Ltd. Company Information
  3. 6.1.2 SpheriTech Ltd. Business Overview
  4. 6.1.3 SpheriTech Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 SpheriTech Ltd. Artificial Blood Products Product Portfolio
  6. 6.1.5 SpheriTech Ltd. Recent Developments
  7. 6.2 NuvOx Pharma
  8. 6.2.1 NuvOx Pharma Company Information
  9. 6.2.2 NuvOx Pharma Business Overview
  10. 6.2.3 NuvOx Pharma Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 NuvOx Pharma Artificial Blood Products Product Portfolio
  12. 6.2.5 NuvOx Pharma Recent Developments
  13. 6.3 KaloCyte Inc.
  14. 6.3.1 KaloCyte Inc. Company Information
  15. 6.3.2 KaloCyte Inc. Business Overview
  16. 6.3.3 KaloCyte Inc. Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 KaloCyte Inc. Artificial Blood Products Product Portfolio
  18. 6.3.5 KaloCyte Inc. Recent Developments
  19. 6.4 HEMARINA SA
  20. 6.4.1 HEMARINA SA Company Information
  21. 6.4.2 HEMARINA SA Business Overview
  22. 6.4.3 HEMARINA SA Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 HEMARINA SA Artificial Blood Products Product Portfolio
  24. 6.4.5 HEMARINA SA Recent Developments
  25. 6.5 HbO2 Therapeutics
  26. 6.5.1 HbO2 Therapeutics Company Information
  27. 6.5.2 HbO2 Therapeutics Business Overview
  28. 6.5.3 HbO2 Therapeutics Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HbO2 Therapeutics Artificial Blood Products Product Portfolio
  30. 6.5.5 HbO2 Therapeutics Recent Developments
  31. 6.6 Aurum Biosciences Ltd.
  32. 6.6.1 Aurum Biosciences Ltd. Company Information
  33. 6.6.2 Aurum Biosciences Ltd. Business Overview
  34. 6.6.3 Aurum Biosciences Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio
  36. 6.6.5 Aurum Biosciences Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Artificial Blood Products Sales by Country
  2. 7.1.1 North America Artificial Blood Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Artificial Blood Products Sales by Country (2021-2026)
  4. 7.1.3 North America Artificial Blood Products Sales Forecast by Country (2027-2032)
  5. 7.2 North America Artificial Blood Products Market Size by Country
  6. 7.2.1 North America Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Artificial Blood Products Market Size by Country (2021-2026)
  8. 7.2.3 North America Artificial Blood Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Artificial Blood Products Sales by Country
  2. 8.1.1 Europe Artificial Blood Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Artificial Blood Products Sales by Country (2021-2026)
  4. 8.1.3 Europe Artificial Blood Products Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Artificial Blood Products Market Size by Country
  6. 8.2.1 Europe Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Artificial Blood Products Market Size by Country (2021-2026)
  8. 8.2.3 Europe Artificial Blood Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Artificial Blood Products Sales by Country
  2. 9.1.1 Asia-Pacific Artificial Blood Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Artificial Blood Products Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Artificial Blood Products Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Artificial Blood Products Market Size by Country
  6. 9.2.1 Asia-Pacific Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Artificial Blood Products Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Artificial Blood Products Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Artificial Blood Products Sales by Country
  2. 10.1.1 South America Artificial Blood Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Artificial Blood Products Sales by Country (2021-2026)
  4. 10.1.3 South America Artificial Blood Products Sales Forecast by Country (2027-2032)
  5. 10.2 South America Artificial Blood Products Market Size by Country
  6. 10.2.1 South America Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Artificial Blood Products Market Size by Country (2021-2026)
  8. 10.2.3 South America Artificial Blood Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Artificial Blood Products Sales by Country
  2. 11.1.1 Middle East and Africa Artificial Blood Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Artificial Blood Products Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Artificial Blood Products Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Artificial Blood Products Market Size by Country
  6. 11.2.1 Middle East and Africa Artificial Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Artificial Blood Products Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Artificial Blood Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Artificial Blood Products Value Chain Analysis
  2. 12.1.1 Artificial Blood Products Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Artificial Blood Products Production Mode & Process
  7. 12.2 Artificial Blood Products Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Artificial Blood Products Distributors
  10. 12.2.3 Artificial Blood Products Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst